![](/img/cover-not-exists.png)
Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601)
Antill, Y., Kok, P.S., Stockler, M.R., Robledo, K., Yip, S., Parry, M., Smith, D., Spurdle, A., Barnes, E., Friedlander, M.L., Baron-Hay, S., Shannon, C., Coward, J., Beale, P.J., Goss, G., Meniawy, TVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz446.011
Date:
November, 2019
File:
PDF, 70 KB
2019